← Back to headlines
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound.
17 Mar, 18:28 — 17 Mar, 18:28
Related Stories
Harvard Psychologist Shares 8 Communication Habits of Emotionally Secure Couples
16m ago
Doctor Hadži Aleksandra Dimitrijević Recovers After Seven Surgeries for Rare Disease
25m ago
Doctor Hadži Aleksandra Dimitrijević Recovers After Seven Surgeries for Rare Disease
25m ago
Experts Share Advice on Preventing Snake Bites
28m ago